logo

Acrivon Therapeutics Inc (ACRV) Stock: A 52-Week Tale of Drops and Gains

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Acrivon Therapeutics Inc’s current trading price is -85.88% away from its 52-week high, while its distance from the 52-week low is -16.83%. The stock’s price range during this period has varied between $2.02 and $11.90. The company, active in the Healthcare sector, saw a trading volume of around 0.57 million for the day, considerably higher average daily volume of 97950.0 observed over the last three months.

Acrivon Therapeutics Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $11.90 on 04/09/24, with the lowest value being $2.02 on 04/01/25.

How Financial Performance Impacts Market Capitalization

Acrivon Therapeutics Inc (ACRV) has experienced a quarterly decline of -71.62% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 52.67M and boasts a workforce of 78 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 5.99, with a change in price of -6.17. Similarly, Acrivon Therapeutics Inc recorded 86,592 in trading volume during the last 100 days, posting a change of -78.60%.

How ACRV’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for ACRV stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.01.

ACRV Stock Stochastic Average

As of today, the raw stochastic average of Acrivon Therapeutics Inc over the past 50 days is 1.86%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 2.86%. Additionally, the Stochastic %K and %D values for the company were 1.97% and 2.18%, respectively, over the past 20 days.

ACRV Stock Price Performance Analysis

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant loss of -72.09% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -76.54%. Over the past 30 days, the price of ACRV has leaped by -67.32%. And in the last five days, it has fallen by -68.83%.

Most Popular